Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Nikki Curry and Ladislav Valkovič who have both received an RDM Award for Excellent Supervision 2026.

Nikki Curry and Ladislav Valkovič

The award recognises exceptional teaching and learning support and mentorship of students.

Associate Professor Nikki Curry was recognised for consistently prioritising her trainees, holding meetings with them which are regular, focused, constructive and genuinely supportive. Nominators praised Nikki's ability to provide a safe and motivating space in which to discuss scientific challenges, refine ideas and plan. Students also appreciate Nikki's interest in their wellbeing and cultivating a collaborative and inclusive lab culture, where mutual support is encouraged and students feel comfortable seeking help. Nominators said that Nicola inspires confidence, independence and ambition in those she supervises, and creates an environment where all those she supervises can thrive academically, professionally and personally.

Nikki commented: 'I am so delighted to have been given this award, and I am genuinely touched that my team nominated me – so thank you to them.'

Professor Ladislav Valkovič was nominated for his dedication, generosity and consistently supportive supervision. Students noted that Ladislav is exceptionally generous with his time, and his availability and willingness to help create an environment where students feel supported, reassured, and confident in tackling challenges. Nominators also praised Ladislav for fostering a collaborative, friendly and inclusive research group, holding weekly meetings which are supportive and built on a culture of openness and mutual help. He also regularly organises board game nights for OCMR which students say have helped strengthen team relationships and creating a relaxing space to unwind during high-demand periods of study and research. Students said Ladislav exemplifies excellence in every aspect of supervision – academic, professional and pastoral.

Ladislav said: 'Being a supervisor and helping young bright minds grow into world-experts is highly satisfying. Reading the kind words of my students is a completely another level, I feel really humbled. My only hope is that I can live up to their praise.'

Nikki and Ladislav will receive their awards at RDM Day on Tuesday 17 March.

Top Tips for excellent mentorship

  • Try to individualise your approach to each mentee (Nikki Curry)
  • Listen – mentorship is not a one-way relationship (Ladislav Valkovič)

Similar stories

Researchers highlight need for better sleep support for NHS shift workers

A new study led by researchers at the University of Oxford’s Radcliffe Department of Medicine, has found that many NHS staff working shifts experience sleep difficulties, with researchers calling for more accessible, evidence-based support to help staff manage sleep.

Oxford spin-out raises $90 million to advance new treatments for blood cancers

Alethio Therapeutics, a University of Oxford spin-out co-founded by Professors Adam Mead and Beth Psaila, has secured $90 million (£67 million) in oversubscribed Series A financing to develop a new generation of therapies for myeloproliferative neoplasms (MPNs).

Breakthrough in non-invasive liver testing

Two major international studies, including an imaging study led by researchers from the Radcliffe Department of Medicine, have provided new evidence on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, potentially reducing reliance on liver biopsy.

Oxford-led research identifies a new therapeutic strategy to reverse established atrial fibrosis in atrial fibrillation

Researchers at the University of Oxford have identified a promising new RNA-based therapeutic approach that can reverse established atrial fibrosis. Atrial fibrosis is a major contributor to atrial fibrillation, the most common sustained cardiac arrhythmia worldwide.

Therapy Acceleration Lab achieves Medical Laboratory Accreditation

The Therapy Acceleration Lab (TAL) at the MRC WIMM has been accredited by the United Kingdom Accreditation Service (UKAS) to ISO 15189:2022 – Medical laboratories – Requirements for quality and competence.

Gene editing points to new treatment approach for inherited blood disorder

Researchers at the MRC Weatherall Institute of Molecular Medicine have used genome editing to reactivate an embryonic globin gene, offering a potential new strategy for treating severe α-thalassaemia.

Similar stories

Researchers highlight need for better sleep support for NHS shift workers

A new study led by researchers at the University of Oxford’s Radcliffe Department of Medicine, has found that many NHS staff working shifts experience sleep difficulties, with researchers calling for more accessible, evidence-based support to help staff manage sleep.

Oxford spin-out raises $90 million to advance new treatments for blood cancers

Alethio Therapeutics, a University of Oxford spin-out co-founded by Professors Adam Mead and Beth Psaila, has secured $90 million (£67 million) in oversubscribed Series A financing to develop a new generation of therapies for myeloproliferative neoplasms (MPNs).

Breakthrough in non-invasive liver testing

Two major international studies, including an imaging study led by researchers from the Radcliffe Department of Medicine, have provided new evidence on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, potentially reducing reliance on liver biopsy.

Oxford-led research identifies a new therapeutic strategy to reverse established atrial fibrosis in atrial fibrillation

Researchers at the University of Oxford have identified a promising new RNA-based therapeutic approach that can reverse established atrial fibrosis. Atrial fibrosis is a major contributor to atrial fibrillation, the most common sustained cardiac arrhythmia worldwide.

Therapy Acceleration Lab achieves Medical Laboratory Accreditation

The Therapy Acceleration Lab (TAL) at the MRC WIMM has been accredited by the United Kingdom Accreditation Service (UKAS) to ISO 15189:2022 – Medical laboratories – Requirements for quality and competence.

Gene editing points to new treatment approach for inherited blood disorder

Researchers at the MRC Weatherall Institute of Molecular Medicine have used genome editing to reactivate an embryonic globin gene, offering a potential new strategy for treating severe α-thalassaemia.